Results 61 to 70 of about 3,931 (193)
Lung transplantation after allogeneic stem cell transplantation : a pan-European experience [PDF]
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transplantation (SCT) recipients within 5 years, conferring subsequent 5-year survival of 50%.
Aubert, John +24 more
core +3 more sources
Abstract Background Specimens contaminated with intravenous (IV) fluids can lead to considerable measurement errors in complete blood counts (CBCs), posing challenges for laboratory operations and clinical decision‐making. There is no gold‐standard method for retrospectively identifying these events, making it difficult to target quality improvement ...
Carly Maucione +5 more
wiley +1 more source
Second-line therapy for corticosteroid-refractory or -dependent acute graft-versus-host disease remains ill-defined, due to limited efficacy of drugs and evolving clinical trial endpoints.
Emma Das-Gupta +10 more
doaj +1 more source
Extracorporeal photopheresis (ECP) has been used as a component of combined immunosuppressive therapy in 53 patients with steroid-refractoryacute “graft-versus-host” disease.
A. V. Kozlov +6 more
doaj +3 more sources
Background: Chronic graft-versus-host disease (cGvHD) is a major complication after allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) is an immunotherapy treatment for cGvHD, although suitable response biomarkers are ...
Sérgio Machado Lopes +7 more
doaj +1 more source
Fotoaferesi extracorporea come terapia di prima linea nel trattamento della GVHD cronica dopo trapianto allogenico di cellule staminali [PDF]
Introduzione. La malattia del trapianto verso l’ospite cronica (cGVHD) è la più importante complicanza dopo trapianto di cellule staminali emopoietiche.
Tendas, Andrea
core
Extracorporeal Photopheresis in Graft-versus-Host Disease
Graft-versus-host disease (GVHD) is a major cause of mortality and morbidity following allogeneic hematopoietic stem cell transplantation. Extracorporeal photopheresis (ECP), which exposes mononuclear cells to ultraviolet A irradiation in the presence of a photosensitizing agent, has shown efficacy in the treatment of GVHD.
Pedro Asensi Cantó +4 more
openaire +4 more sources
Suppressive CD8+ T‐Cells Are Key Cellular Mediators of Extracorporeal Photopheresis
ABSTRACT Extracorporeal photopheresis (ECP) is a widely utilized immunomodulatory procedure with an incompletely defined mechanism. In graft‐versus‐host disease (GvHD) and transplant rejection, ECP is thought to induce immune tolerance by increasing regulatory CD4+ T‐cells, whereas in cutaneous T cell lymphoa it may enhance dendritic cell–mediated ...
Kai J. Rogers +7 more
wiley +1 more source
This EBMT Practice Harmonisation and Guidelines Committee consensus provides practical recommendations for the selection, timing and conduct of allogeneic transplantation in advanced‐stage mycosis fungoides and Sézary syndrome, aiming to optimize outcomes through early multidisciplinary collaboration and evidence‐based decision‐making.
Gandhi Damaj +26 more
wiley +1 more source
Extracorporeal photopheresis—New insights into an old procedure
Abstract Background Extracorporeal photopheresis (ECP) is a safe immunomodulatory strategy that induces cell‐type selective apoptosis through photodynamic processes. Despite decades of use, the mechanisms underlying ECP remain largely unexplored, particularly in studies examining specific immune cell subsets in ex vivo setups.
Sabine Seiffert +10 more
wiley +1 more source

